有効成分市場：医薬品、農薬、パーソナルケア・化粧品、地域別、2024年～2031年

有効成分市場の評価、2024年～2031年

有効成分に対する需要の高まりは、健康・ウェルネス商品に対する顧客の知識と嗜好の高まりによるところが大きいです。医薬品、化粧品、パーソナルケア製品、その他の健康関連商品の重要な成分である有効成分は、望ましい治療効果や美容効果を得る上で重要な役割を果たします。個人の健康志向が高まるにつれ、アンチエイジング、美白、免疫力向上など特殊な効果をもたらす製品への需要が高まり、2024年には28億3,000万米ドルの売上を突破し、2031年には41億5,000万米ドルの評価額に達する見込みです。

有効成分市場は、技術的・科学的ブレークスルーにより拡大しています。バイオテクノロジー、ナノテクノロジー、合成生物学の進歩により、より強力で効果的な活性物質の創出が可能になった。例えば、スキンケアにナノテクノロジーを利用することで、活性化合物の吸収が改善され、効力が高まる。さらに、医薬品事業では、慢性疾患、がん、精神的健康問題に対する治療など、満たされていない医療ニーズに対応するため、常に新規有効成分の研究開発が行われています。このため、市場は2024年から2031年までCAGR 4.90%で成長します。

有効成分市場定義/概要

有効成分とは、製品が適切に機能するための主要成分です。医薬品の場合、有効成分は病気や症状の直接的な治療や管理を行う化学成分です。例えば、鎮痛剤であるイブプロフェンの有効成分は、痛みや炎症を抑える役割を担っています。活性化学物質は、ある製品を他の製品と区別し、その機能を決定します。

有効成分とは、医薬品、化粧品、農産物のいずれにおいても、望ましい結果を生み出す製品中の物質です。医薬品では、有効成分は治療上の利点をもたらす主成分です。例えば、鎮痛剤の場合、有効成分は炎症や痛みを抑えるイブプロフェンかもしれないです。これらの化学物質は、特定の症状や病気に対処するために慎重に選択され、薬の効果を保証します。

医薬品、化粧品、農業に代表される活性化合物の将来的な利用法は、画期的な進歩を遂げる可能性が高いです。有効成分は、治療効果をもたらす医薬品の主成分です。バイオテクノロジーとオーダーメイド医療の進歩により、将来は、特定の遺伝子プロファイルに対応した、よりテーラーメイドの有効成分が主流になることは間違いないです。つまり、各個人の生物学的組成に合わせれば、治療がより成功し、悪影響が少なくなる可能性があるということです。

医薬品製造における広範な使用は有効成分市場を牽引するか？

医薬品製造における有効成分の広範な使用は、有効成分市場の主要促進要因です。この動向は、人口の増加、平均寿命の延長、慢性疾患の増加といった要因に後押しされた世界の医薬品需要の高まりによって推進されています。世界保健機関（WHO）によると、2018年の世界の医療支出は8兆3,000億米ドルで、世界GDPの10％を占めています。ヘルスケアへの多額の投資により、医薬品、ひいては有効成分の需要が増加しています。

米国食品医薬品局（FDA）によると、2020年には53の革新的な医薬品が承認され、医薬品業界の継続的な革新と成長を実証しています。新しい医薬品の開発が進むことは、有効成分産業の成長に直接的な影響を与えます。医薬品製造における有効成分の広範な使用は、有効成分市場の主要な促進要因です。この動向は、人口の増加、平均寿命の延長、慢性疾患の増加といった要因に後押しされた世界の医薬品需要の高まりによって推進されています。世界保健機関（WHO）によると、2018年の世界の医療支出は8兆3,000億米ドルで、世界GDPの10％を占めています。ヘルスケアへの多額の投資により、医薬品、ひいては有効成分の需要が増加しています。米国食品医薬品局（FDA）によると、2020年には53の革新的な医薬品が承認され、医薬品業界の継続的な革新と成長を実証しています。新薬の開発が進むことは、原薬業界の成長に直接的な影響を与えます。

規制制限は有効成分市場の妨げになるか？

規制上の制限は有効成分市場にとって重要な障害となり、その成長と開拓を阻害する可能性があります。特に製薬・農薬業界では、新規有効成分のクリアランス・プロセスが厳しいことが、規制上の大きな障壁となっています。米国食品医薬品局（FDA）によると、新薬承認申請には平均約12ヶ月かかるが、複雑な申請ではそれ以上かかるものもあります。この長期化したタイムラインは、革新的な品目の市場開拓を遅らせ、企業の開発費を増大させる可能性があります。

さらに、欧州医薬品庁（EMA）の報告によると、新規活性物質の評価期間は平均約423日で、主要市場における規制対応に時間がかかることが浮き彫りになっています。もう一つの重要な規制上の制約は、環境・安全規制の重視の高まりです。欧州化学物質庁（ECHA）は、化学物質の登録、評価、認可および制限に関する法律（REACH）を施行し、毎年1トン以上生産または輸入される化学物質の登録を企業に義務付けています。さらに米国環境保護庁（EPA）は、2020会計年度に22,000以上の農薬製品レビューを完了したと報告しており、農薬業界における規制監視の充実ぶりを示しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 有効成分市場：医薬品別

• 処方薬
• 一般用医薬品
• 生物学的製品

第5章 有効成分市場：農薬別

• 除草剤
• 殺虫剤
• 殺菌剤
• 植物成長調節剤

第6章 有効成分市場：パーソナルケア・化粧品別

• スキンケア製品
• ヘアケア製品
• 化粧品

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Pfizer
• Merck & Co.
• Roche
• Novartis
• Johnson & Johnson
• BASF SE
• Dow Chemical Company
• Evonik Industries
• Ashland Inc.
• Clariant

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Active Ingredients Market Valuation - 2024-2031

The rising demand for active ingredients is largely due to increased customer knowledge and preference for health and wellness goods. Active ingredients which are critical components of medications, cosmetics, personal care products, and other health-related items play an important role in achieving the desired therapeutic or cosmetic outcome. As individuals grow more health-conscious, there is a greater demand for products that provide specialized benefits such as anti-aging, skin brightening, immune boosters, and other targeted impacts by enabling the market to surpass a revenue of USD 2.83 Billion valued in 2024 and reach a valuation of around USD 4.15 Billion by 2031.

The active ingredients market is expanding due to technological and scientific breakthroughs. Biotechnology, nanotechnology, and synthetic biology advancements have made it possible to create more potent and effective active substances. For example, using nanotechnology in skincare improves the absorption of active compounds, increasing their potency. Furthermore, the pharmaceutical business is always researching and developing novel active ingredients to meet unmet medical requirements such as therapies for chronic diseases, cancer, and mental health issues. This enables the market to grow at aCAGR of 4.90% from 2024 to 2031.

Active Ingredients Market: Definition/ Overview

Active ingredients are the key components of a product that allow it to work properly. In the case of pharmaceuticals, the active ingredient is a chemical component that directly treats or manages the symptoms of a disease or condition. For example, the active component in ibuprofen, a pain reliever is responsible for lowering pain and inflammation. Active chemicals distinguish one product from another and determine how it functions.

Active ingredients are substances in products that create the desired results whether in medications, cosmetics, or agricultural products. In medicines, active ingredients are the primary components that provide therapeutic advantages. For example, in pain relievers, the active ingredient may be ibuprofen which decreases inflammation and pain. These chemicals are carefully chosen to address specific symptoms or illnesses assuring the medication's efficacy.

The future usage of active compounds, notably in pharmaceuticals, cosmetics, and agriculture, is likely to be revolutionary as breakthroughs arise. Active ingredients are the primary components of medications that provide therapeutic effects. With advances in biotechnology and customized medicine, the future will most certainly see a trend toward more tailored active ingredients that cater to specific genetic profiles. This means that therapies may become more successful and have fewer negative effects if they are tailored to each individual's biological composition.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Extensive Use in Drug Manufacturing Drive the Active Ingredients Market?

The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018, accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and, by extension, active ingredients.

The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry. The extensive usage of active ingredients in medicine manufacture is a major driver of the active ingredients market. This trend is propelled by rising global demand for pharmaceuticals which is being driven by factors such as population expansion, longer life expectancy, and an increase in the prevalence of chronic diseases. According to the World Health Organization (WHO), worldwide health spending was USD 8.3 Trillion in 2018 accounting for 10% of global GDP. This significant investment in healthcare results in increasing demand for pharmaceuticals and by extension, active ingredients. The United States Food and Drug Administration (FDA) states that 53 innovative medications were approved in 2020 demonstrating the pharmaceutical industry's continued innovation and growth. The ongoing development of new pharmaceuticals has a direct impact on the growth of the active ingredients industry.

Will the Regulatory Constraints Hamper the Active Ingredients Market?

Regulatory limits present important obstacles for the active ingredients market, potentially impeding its growth and development. The demanding clearance process for new active ingredients, notably in the pharmaceutical and agrochemical industries is a significant regulatory barrier. According to the United States Food and Drug Administration (FDA), the average time for approving a new drug application is about 12 months with some complex applications taking considerably longer. This prolonged timeline may delay market introduction for innovative items and increase the company's development expenses.

Furthermore, the European Medicines Agency (EMA) reports that the average period for evaluating a new active substance is approximately 423 days highlighting the time-consuming nature of regulatory compliance in key markets. Another key regulatory restraint is an increased emphasis on environmental and safety regulations. The European Chemicals Agency (ECHA) enforces the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) law which requires enterprises to register chemical substances produced or imported in quantities of one tonne or more each year. Furthermore, the United States Environmental Protection Agency (EPA) reported completing over 22,000 pesticide product reviews in fiscal year 2020 indicating substantial regulatory monitoring in the agrochemical industry.

Category-Wise Acumens

Will a Wide Range of Serious and Chronic Medical Conditions Drive Growth in the Pharmaceutical Segment?

Prescription medications dominate because of their importance in treating a wide spectrum of serious and chronic medical disorders. Prescription medications contain active chemicals that have been precisely designed and approved for targeted therapies which are frequently used to treat complicated conditions such as cancer, cardiovascular difficulties, and autoimmune disorders. These active chemicals go through extensive research and clinical trials to confirm their efficacy and safety making them indispensable in modern medicine. The increased frequency of chronic diseases, an aging population, and ongoing innovation in medication development all contribute to prescription pharmaceutical supremacy.

Pharmaceutical companies invest extensively in research and development to generate new active components that can deliver more effective treatments with fewer side effects highlighting the importance of prescription pharmaceuticals. OTC medications and biological products play important roles in the market but they do not supplant prescription drugs. OTC medications while necessary for treating common and less severe illnesses, often contain well-established active components and do not require doctor supervision resulting in lower regulatory obstacles and research expenditure when compared to prescription drugs.

Will the Growing Consumer Awareness Drive the Personal Care and Cosmetics Segment?

Skincare goods segment is projected to dominate the market over the forecast period. This dominance is driven by increasing consumer awareness and concern about skin health, aging, and general skin look. Moisturizers, anti-aging creams, and treatments for acne and hyperpigmentation are becoming increasingly popular as customers prioritize preserving a young appearance and addressing specific skin ailments. The global increase in pollution, stress, and UV radiation has increased the demand for effective skincare solutions resulting in a spike in the discovery and application of new active ingredients.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers changing wants.

Country/Region-wise Acumens

Will the Rising Prevalence of Preventable Chronic Diseases Drive the Market in the North American Region?

The growing frequency of avoidable chronic diseases in North America is primarily driving the market for active ingredients. This tendency is especially noticeable in the United States which accounts for a sizable chunk of the industry. The increasing frequency of chronic diseases in North America is a significant driver of the active ingredients market. According to the Centers for Disease Control and Prevention (CDC), six out of ten persons in the United States have a chronic disease with four out of ten having two or more chronic disorders. These astonishing figures underline the critical need for improved treatments and prevention strategies.

Chronic diseases impose an equal economic impact with the National Center for Chronic Disease Prevention and Health Promotion claiming that people with chronic and mental health conditions account for 90% of the nation's $3.8 trillion in yearly health care costs. This significant economic impact highlights the significance of treating chronic diseases and increases demand for active ingredients in medicines and nutraceuticals. The active ingredients market is also being boosted by the increased awareness of preventive healthcare measures among North Americans. The Healthy People 2030 effort launched by the United States Department of Health and Human Services seeks to reduce the burden of preventable diseases by encouraging health and wellness.

Will the Rapid Urbanization and an Expanding Middle-Class Population Drive the Market in the Asia Pacific Region?

The Asia Pacific region is witnessing the world's fastest urbanization rate with China and India leading the way. This fast urbanization combined with a rapidly rising middle-class population is expected to be a big driver of the region's active ingredients market. Urbanization in Asia Pacific is accelerating at an unprecedented rate. According to the United Nations Department of Economic and Social Affairs, Asia's urban population is expected to grow from 2.2 billion in 2020 to 3.5 billion in 2050. China alone is estimated to add 255 million urban residents between 2020 and 2050. This tremendous change to urban living is accompanied by changing lifestyles, higher disposable incomes, and heightened knowledge of personal care and health products.

Skincare's dominance in the active ingredients market is further bolstered by rising demand for multifunctional products that provide several advantages such as hydration, UV protection, and anti-aging qualities. As the world's population ages, there is a greater emphasis on anti-aging products which frequently attract higher prices due to their claimed efficacy and utilization of cutting-edge active ingredients. This has pushed businesses to invest extensively in R&D to innovate and create new active ingredients that can meet consumers' changing wants. Additionally, the rise of personalized skincare in which products are tailored to individual skin types and conditions has led to greater use of specific active ingredients that address unique concerns, further driving the market growth.

Competitive Landscape

The Active Ingredients Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the active ingredients market include:

BASF SE

The Dow Chemicals Company

Ashland, Inc.

Rhodia

Du Pont

Sumitomo Group

LOral S.A.

Beiersdorf AG

Sederma, Inc.

Evonik Industries

Latest Developments

In October 2020, Evonik significantly increased its bio-based line of active ingredients for the beauty and personal care industries in response to rising demand for innovative, sustainably sourced products.

In April 2021, Ashland announced a new active skin care component, claiming to enhance vibrancy and "glow" for a well-aged appearance.

TABLE OF CONTENTS

1.Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Active Ingredients Market, By Pharmaceuticals

• Prescription Drugs
• Over-the-Counter (OTC) Drugs
• Biological Products

5 Active Ingredients Market, By Agrochemicals

• Herbicides
• Insecticides
• Fungicides
• Plant Growth Regulators

6 Active Ingredients Market, By Personal Care and Cosmetics

• Skin Care Products
• Hair Care Products
• Cosmetics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Pfizer
• Merck & Co.
• Roche
• Novartis
• Johnson & Johnson
• BASF SE
• Dow Chemical Company
• Evonik Industries
• Ashland Inc.
• Clariant

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References